Global Inactivated Influenza Vaccine Market Research Report 2023

Report ID: 1749882 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Inactivated Influenza Vaccine Market Overview
    1.1 Product Overview and Scope of Inactivated Influenza Vaccine
    1.2 Inactivated Influenza Vaccine Segment by Type
        1.2.1 Global Inactivated Influenza Vaccine Market Value Comparison by Type (2023-2029)
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Inactivated Influenza Vaccine Segment by Application
        1.3.1 Global Inactivated Influenza Vaccine Market Value by Application: (2023-2029)
        1.3.2 Children
        1.3.3 Adolescence
        1.3.4 Adults
        1.3.5 Elderly
    1.4 Global Inactivated Influenza Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Inactivated Influenza Vaccine Revenue 2018-2029
        1.4.2 Global Inactivated Influenza Vaccine Sales 2018-2029
        1.4.3 Global Inactivated Influenza Vaccine Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Inactivated Influenza Vaccine Market Competition by Manufacturers
    2.1 Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Inactivated Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Inactivated Influenza Vaccine Average Price by Manufacturers (2018-2023)
    2.4 Global Inactivated Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Inactivated Influenza Vaccine, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Inactivated Influenza Vaccine, Product Type & Application
    2.7 Inactivated Influenza Vaccine Market Competitive Situation and Trends
        2.7.1 Inactivated Influenza Vaccine Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Inactivated Influenza Vaccine Players Market Share by Revenue
        2.7.3 Global Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inactivated Influenza Vaccine Retrospective Market Scenario by Region
    3.1 Global Inactivated Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Inactivated Influenza Vaccine Global Inactivated Influenza Vaccine Sales by Region: 2018-2029
        3.2.1 Global Inactivated Influenza Vaccine Sales by Region: 2018-2023
        3.2.2 Global Inactivated Influenza Vaccine Sales by Region: 2024-2029
    3.3 Global Inactivated Influenza Vaccine Global Inactivated Influenza Vaccine Revenue by Region: 2018-2029
        3.3.1 Global Inactivated Influenza Vaccine Revenue by Region: 2018-2023
        3.3.2 Global Inactivated Influenza Vaccine Revenue by Region: 2024-2029
    3.4 North America Inactivated Influenza Vaccine Market Facts & Figures by Country
        3.4.1 North America Inactivated Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Inactivated Influenza Vaccine Sales by Country (2018-2029)
        3.4.3 North America Inactivated Influenza Vaccine Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Inactivated Influenza Vaccine Market Facts & Figures by Country
        3.5.1 Europe Inactivated Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Inactivated Influenza Vaccine Sales by Country (2018-2029)
        3.5.3 Europe Inactivated Influenza Vaccine Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Inactivated Influenza Vaccine Market Facts & Figures by Country
        3.6.1 Asia Pacific Inactivated Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Inactivated Influenza Vaccine Sales by Country (2018-2029)
        3.6.3 Asia Pacific Inactivated Influenza Vaccine Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Inactivated Influenza Vaccine Market Facts & Figures by Country
        3.7.1 Latin America Inactivated Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Inactivated Influenza Vaccine Sales by Country (2018-2029)
        3.7.3 Latin America Inactivated Influenza Vaccine Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Inactivated Influenza Vaccine Market Facts & Figures by Country
        3.8.1 Middle East and Africa Inactivated Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Inactivated Influenza Vaccine Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E
4 Segment by Type
    4.1 Global Inactivated Influenza Vaccine Sales by Type (2018-2029)
        4.1.1 Global Inactivated Influenza Vaccine Sales by Type (2018-2023)
        4.1.2 Global Inactivated Influenza Vaccine Sales by Type (2024-2029)
        4.1.3 Global Inactivated Influenza Vaccine Sales Market Share by Type (2018-2029)
    4.2 Global Inactivated Influenza Vaccine Revenue by Type (2018-2029)
        4.2.1 Global Inactivated Influenza Vaccine Revenue by Type (2018-2023)
        4.2.2 Global Inactivated Influenza Vaccine Revenue by Type (2024-2029)
        4.2.3 Global Inactivated Influenza Vaccine Revenue Market Share by Type (2018-2029)
    4.3 Global Inactivated Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
    5.1 Global Inactivated Influenza Vaccine Sales by Application (2018-2029)
        5.1.1 Global Inactivated Influenza Vaccine Sales by Application (2018-2023)
        5.1.2 Global Inactivated Influenza Vaccine Sales by Application (2024-2029)
        5.1.3 Global Inactivated Influenza Vaccine Sales Market Share by Application (2018-2029)
    5.2 Global Inactivated Influenza Vaccine Revenue by Application (2018-2029)
        5.2.1 Global Inactivated Influenza Vaccine Revenue by Application (2018-2023)
        5.2.2 Global Inactivated Influenza Vaccine Revenue by Application (2024-2029)
        5.2.3 Global Inactivated Influenza Vaccine Revenue Market Share by Application (2018-2029)
    5.3 Global Inactivated Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
    6.1 CSL Limited
        6.1.1 CSL Limited Corporation Information
        6.1.2 CSL Limited Description and Business Overview
        6.1.3 CSL Limited Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 CSL Limited Inactivated Influenza Vaccine Product Portfolio
        6.1.5 CSL Limited Recent Developments/Updates
    6.2 GSK
        6.2.1 GSK Corporation Information
        6.2.2 GSK Description and Business Overview
        6.2.3 GSK Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 GSK Inactivated Influenza Vaccine Product Portfolio
        6.2.5 GSK Recent Developments/Updates
    6.3 Sanofi Pasteur
        6.3.1 Sanofi Pasteur Corporation Information
        6.3.2 Sanofi Pasteur Description and Business Overview
        6.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Product Portfolio
        6.3.5 Sanofi Pasteur Recent Developments/Updates
    6.4 Viatris
        6.4.1 Viatris Corporation Information
        6.4.2 Viatris Description and Business Overview
        6.4.3 Viatris Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Viatris Inactivated Influenza Vaccine Product Portfolio
        6.4.5 Viatris Recent Developments/Updates
    6.5 Hualan Biological
        6.5.1 Hualan Biological Corporation Information
        6.5.2 Hualan Biological Description and Business Overview
        6.5.3 Hualan Biological Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Hualan Biological Inactivated Influenza Vaccine Product Portfolio
        6.5.5 Hualan Biological Recent Developments/Updates
    6.6 AstraZeneca
        6.6.1 AstraZeneca Corporation Information
        6.6.2 AstraZeneca Description and Business Overview
        6.6.3 AstraZeneca Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 AstraZeneca Inactivated Influenza Vaccine Product Portfolio
        6.6.5 AstraZeneca Recent Developments/Updates
    6.7 Sinovac Biotech
        6.6.1 Sinovac Biotech Corporation Information
        6.6.2 Sinovac Biotech Description and Business Overview
        6.6.3 Sinovac Biotech Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Sinovac Biotech Inactivated Influenza Vaccine Product Portfolio
        6.7.5 Sinovac Biotech Recent Developments/Updates
    6.8 Aleph Biomedical
        6.8.1 Aleph Biomedical Corporation Information
        6.8.2 Aleph Biomedical Description and Business Overview
        6.8.3 Aleph Biomedical Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Aleph Biomedical Inactivated Influenza Vaccine Product Portfolio
        6.8.5 Aleph Biomedical Recent Developments/Updates
    6.9 Abbott Laboratories
        6.9.1 Abbott Laboratories Corporation Information
        6.9.2 Abbott Laboratories Description and Business Overview
        6.9.3 Abbott Laboratories Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Abbott Laboratories Inactivated Influenza Vaccine Product Portfolio
        6.9.5 Abbott Laboratories Recent Developments/Updates
    6.10 Novartis International
        6.10.1 Novartis International Corporation Information
        6.10.2 Novartis International Description and Business Overview
        6.10.3 Novartis International Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Novartis International Inactivated Influenza Vaccine Product Portfolio
        6.10.5 Novartis International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Inactivated Influenza Vaccine Industry Chain Analysis
    7.2 Inactivated Influenza Vaccine Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Inactivated Influenza Vaccine Production Mode & Process
    7.4 Inactivated Influenza Vaccine Sales and Marketing
        7.4.1 Inactivated Influenza Vaccine Sales Channels
        7.4.2 Inactivated Influenza Vaccine Distributors
    7.5 Inactivated Influenza Vaccine Customers
8 Inactivated Influenza Vaccine Market Dynamics
    8.1 Inactivated Influenza Vaccine Industry Trends
    8.2 Inactivated Influenza Vaccine Market Drivers
    8.3 Inactivated Influenza Vaccine Market Challenges
    8.4 Inactivated Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

List of Tables
    Table 1. Global Inactivated Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Inactivated Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Inactivated Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Inactivated Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Inactivated Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Inactivated Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Inactivated Influenza Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Inactivated Influenza Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Inactivated Influenza Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Inactivated Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Inactivated Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Inactivated Influenza Vaccine Sales by Region (2018-2023) & (K Units)
    Table 18. Global Inactivated Influenza Vaccine Sales Market Share by Region (2018-2023)
    Table 19. Global Inactivated Influenza Vaccine Sales by Region (2024-2029) & (K Units)
    Table 20. Global Inactivated Influenza Vaccine Sales Market Share by Region (2024-2029)
    Table 21. Global Inactivated Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2018-2023)
    Table 23. Global Inactivated Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2024-2029)
    Table 25. North America Inactivated Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Inactivated Influenza Vaccine Sales by Country (2018-2023) & (K Units)
    Table 27. North America Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
    Table 28. North America Inactivated Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Inactivated Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Inactivated Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Inactivated Influenza Vaccine Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Inactivated Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Inactivated Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Inactivated Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Inactivated Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Inactivated Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Inactivated Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Inactivated Influenza Vaccine Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Inactivated Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Inactivated Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Inactivated Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Inactivated Influenza Vaccine Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Inactivated Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Inactivated Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Inactivated Influenza Vaccine Sales (K Units) by Type (2018-2023)
    Table 51. Global Inactivated Influenza Vaccine Sales (K Units) by Type (2024-2029)
    Table 52. Global Inactivated Influenza Vaccine Sales Market Share by Type (2018-2023)
    Table 53. Global Inactivated Influenza Vaccine Sales Market Share by Type (2024-2029)
    Table 54. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Inactivated Influenza Vaccine Revenue Market Share by Type (2018-2023)
    Table 57. Global Inactivated Influenza Vaccine Revenue Market Share by Type (2024-2029)
    Table 58. Global Inactivated Influenza Vaccine Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Inactivated Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Inactivated Influenza Vaccine Sales (K Units) by Application (2018-2023)
    Table 61. Global Inactivated Influenza Vaccine Sales (K Units) by Application (2024-2029)
    Table 62. Global Inactivated Influenza Vaccine Sales Market Share by Application (2018-2023)
    Table 63. Global Inactivated Influenza Vaccine Sales Market Share by Application (2024-2029)
    Table 64. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Inactivated Influenza Vaccine Revenue Market Share by Application (2018-2023)
    Table 67. Global Inactivated Influenza Vaccine Revenue Market Share by Application (2024-2029)
    Table 68. Global Inactivated Influenza Vaccine Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Inactivated Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
    Table 70. CSL Limited Corporation Information
    Table 71. CSL Limited Description and Business Overview
    Table 72. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. CSL Limited Inactivated Influenza Vaccine Product
    Table 74. CSL Limited Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. GSK Inactivated Influenza Vaccine Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Sanofi Pasteur Corporation Information
    Table 81. Sanofi Pasteur Description and Business Overview
    Table 82. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Sanofi Pasteur Inactivated Influenza Vaccine Product
    Table 84. Sanofi Pasteur Recent Developments/Updates
    Table 85. Viatris Corporation Information
    Table 86. Viatris Description and Business Overview
    Table 87. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Viatris Inactivated Influenza Vaccine Product
    Table 89. Viatris Recent Developments/Updates
    Table 90. Hualan Biological Corporation Information
    Table 91. Hualan Biological Description and Business Overview
    Table 92. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Hualan Biological Inactivated Influenza Vaccine Product
    Table 94. Hualan Biological Recent Developments/Updates
    Table 95. AstraZeneca Corporation Information
    Table 96. AstraZeneca Description and Business Overview
    Table 97. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. AstraZeneca Inactivated Influenza Vaccine Product
    Table 99. AstraZeneca Recent Developments/Updates
    Table 100. Sinovac Biotech Corporation Information
    Table 101. Sinovac Biotech Description and Business Overview
    Table 102. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Sinovac Biotech Inactivated Influenza Vaccine Product
    Table 104. Sinovac Biotech Recent Developments/Updates
    Table 105. Aleph Biomedical Corporation Information
    Table 106. Aleph Biomedical Description and Business Overview
    Table 107. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Aleph Biomedical Inactivated Influenza Vaccine Product
    Table 109. Aleph Biomedical Recent Developments/Updates
    Table 110. Abbott Laboratories Corporation Information
    Table 111. Abbott Laboratories Description and Business Overview
    Table 112. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Abbott Laboratories Inactivated Influenza Vaccine Product
    Table 114. Abbott Laboratories Recent Developments/Updates
    Table 115. Novartis International Corporation Information
    Table 116. Novartis International Description and Business Overview
    Table 117. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Novartis International Inactivated Influenza Vaccine Product
    Table 119. Novartis International Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Inactivated Influenza Vaccine Distributors List
    Table 123. Inactivated Influenza Vaccine Customers List
    Table 124. Inactivated Influenza Vaccine Market Trends
    Table 125. Inactivated Influenza Vaccine Market Drivers
    Table 126. Inactivated Influenza Vaccine Market Challenges
    Table 127. Inactivated Influenza Vaccine Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Inactivated Influenza Vaccine
    Figure 2. Global Inactivated Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Inactivated Influenza Vaccine Market Share by Type in 2022 & 2029
    Figure 4. Trivalent Influenza Vaccine Product Picture
    Figure 5. Quadrivalent Influenza Vaccine Product Picture
    Figure 6. Global Inactivated Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Inactivated Influenza Vaccine Market Share by Application in 2022 & 2029
    Figure 8. Children
    Figure 9. Adolescence
    Figure 10. Adults
    Figure 11. Elderly
    Figure 12. Global Inactivated Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Inactivated Influenza Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Inactivated Influenza Vaccine Sales (2018-2029) & (K Units)
    Figure 15. Global Inactivated Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
    Figure 16. Inactivated Influenza Vaccine Report Years Considered
    Figure 17. Inactivated Influenza Vaccine Sales Share by Manufacturers in 2022
    Figure 18. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Inactivated Influenza Vaccine Players: Market Share by Revenue in 2022
    Figure 20. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Inactivated Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Inactivated Influenza Vaccine Sales Market Share by Country (2018-2029)
    Figure 23. North America Inactivated Influenza Vaccine Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Inactivated Influenza Vaccine Sales Market Share by Country (2018-2029)
    Figure 27. Europe Inactivated Influenza Vaccine Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Inactivated Influenza Vaccine Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Inactivated Influenza Vaccine Revenue Market Share by Region (2018-2029)
    Figure 35. China Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Taiwan Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Philippines Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Inactivated Influenza Vaccine Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Inactivated Influenza Vaccine Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Inactivated Influenza Vaccine Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Inactivated Influenza Vaccine Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. U.A.E Inactivated Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Inactivated Influenza Vaccine by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Inactivated Influenza Vaccine by Type (2018-2029)
    Figure 57. Global Inactivated Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Inactivated Influenza Vaccine by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Inactivated Influenza Vaccine by Application (2018-2029)
    Figure 60. Global Inactivated Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
    Figure 61. Inactivated Influenza Vaccine Value Chain
    Figure 62. Inactivated Influenza Vaccine Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Frequently Asked Questions
Inactivated Influenza Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inactivated Influenza Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inactivated Influenza Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Audience Seating

This report aims to provide a comprehensive presentation of the global market for Audience Seatin ... Read More